Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
Clinical trial NCT03212742 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03212742
- Sponsor
- Centre Francois Baclesse
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-04
- Primary completion
- 2026-09-13
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.